Skip to main content

Table 4 Subgroup analyses: modified Rankin Scale (mRS) at baseline, 3 and 6 months and mRS change scores, according to primary discharge destination in 306 ESD Stroke Bergen study patients

From: Early supported discharge after stroke in Bergen (ESD Stroke Bergen): three and six months results of a randomised controlled trial comparing two early supported discharge schemes with treatment as usual

Discharge destination

ESD 1 group

ESD 2 group

Control group

p-value*

Home (n=171); mean (SD) (n)

          

  Baseline

1.72

(0.88)

(54)

1.97

(0.94)

(60)

1.89

(0.88)

(57)

0.359

  3 months

1.69

(1.15)

(39)

1.74

(1.16)

(50)

1.93

(1.00)

(44)

0.461

  6 months

1.66

(1.15)

(41)

2.00

(1.30)

(45)

1.94

(1.15)

(36)

0.514

  Change score 0–3 months

−0.18

(0.94)

(39)

−0.26

(1.23)

(50)

0.07

(1.09)

(44)

0.252

  Change score 0–6 months

−0.10

(1.04)

(41)

−0.05

(1.33)

(45)

0.06

(1.24)

(36)

0.820

Municipal Institution (n = 78); mean (SD) (n)

          

  Baseline

3.77

(0.75)

(22)

3.56

(0.87)

(25)

3.65

(0.84)

(31)

0.588

  3 months

3.50

(1.19)

(20)

3.35

(1.30)

(23)

3.83

(1.29)

(18)

0.521

  6 months

3.60

(1.19)

(20)

3.41

(1.44)

(22)

3.71

(1.52)

(21)

0.858

  Change score 0–3 months

−0.25

(0.79)

(20)

−0.30

(1.18)

(23)

0.00

(1.19)

(18)

0.509

  Change score 0–6 months

−0.15

(0.81)

(20)

−0.05

(1.46)

(22)

0.05

(1.28)

(21)

0.881

DPMR (n = 47); mean (SD) (n)

          

  Baseline

3.26

(1.05)

(19)

3.22

(0.73)

(18)

3.70

(0.67)

(10)

0.378

  3 months

2.76

(0.97)

(17)

2.33

(0.72)

(15)

3.25

(0.71)

(8)

0.041

  6 months

2.50

(1.29)

(14)

2.21

(0.89)

(14)

3.25

(0.71)

(8)

0.037

  Change score 0–3 months

−0.41

(1.00)

(17)

−0.93

(0.96)

(15)

−0.50

(0.53)

(8)

0.258

  Change score 0–6 months

−0.79

(1.37)

(14)

−1.00

(0.88)

(14)

−0.50

(0.53)

(8)

0.492

  1. Abbreviations: ESD Early Supported Discharge; SD standard deviation, DPMR Department of Physical Medicine and Rehabilitation.
  2. *All analyses: Kruskal-Wallis test, p-values <0.05 indicated in bold.